Core Insights - Solésence, Inc. achieved record revenue of $62.1 million in 2025, doubling its consumer product line in two years, highlighting its position as a leading innovator in SPF-infused beauty products [3][4] - The company launched a strategic initiative called Transform & Transcend, aimed at aligning operational execution with organizational changes due to rapid growth, focusing on operational excellence, technology-driven market expansion, service model innovation, and collaborative globalization [4] Financial Performance - For the fourth quarter of 2025, revenue was $12.5 million, slightly down from $12.6 million in the same period of 2024, while gross profit increased to $3.4 million from $2.8 million year-over-year [8] - The gross margin for Q4 2025 was 27%, up from 22% in Q4 2024, and net income for the quarter was approximately $0.2 million, a significant improvement from a net loss of approximately $0.6 million in Q4 2024 [8] - For the full year 2025, revenue increased by 19% to $62.1 million compared to $52.3 million in 2024, while gross profit was $16.1 million, slightly down from $16.2 million in 2024 [8][6] - The gross margin for the full year 2025 was 26%, down from 31% in 2024, and net income for the year was $1.8 million, a decrease from $4.2 million in 2024 [8][6] Strategic Developments - The company appointed Yoolie Park as Vice President of Brand Partnerships to enhance commercialization strategy and deepen relationships with beauty brand partners [8] - Solésence acquired 20 new brand partners in facial skincare and color cosmetics, expanding its market presence [8] - The company also expanded its skin health patent protection with 16 new U.S. and foreign patents, including additional global protection for its Kleair™ technology, set to launch in 2026 [8]

Core Insights - Solésence, Inc. reported record revenue of $14.6 million for Q1 2025, a 48% increase from $9.9 million in Q1 2024, driven by strong sales and large customer orders [7][2] - The company experienced a significant increase in shipment volume by 95% year-over-year and production volume by 120% year-over-year, indicating robust operational growth [7][2] - Solésence has successfully uplisted to Nasdaq under the ticker "SLSN," enhancing its visibility in the investment community [6][2] Financial Performance - Revenue for Q1 2025 was $14.6 million, up from $9.9 million in Q1 2024, marking a 48% increase [7] - Gross profit decreased to $3.3 million in Q1 2025 from $3.6 million in Q1 2024, resulting in a gross margin of 23%, down from 36% in the previous year [7] - Net income for Q1 2025 was breakeven, compared to a net income of $0.9 million in Q1 2024 [7] Operational Highlights - The company launched a multi-SKU product line for a new strategic brand partner, which incurred one-time start-up costs affecting gross margins [2] - Solésence anticipates continued sequential revenue growth with current shipped and open orders exceeding $45 million [2] - The company has expanded its intellectual property portfolio with new technology allowances in Japan, South Korea, and Mexico [7] Future Outlook - Management expects substantial improvement in gross margin levels as operations scale and fixed manufacturing costs are managed more efficiently [2] - The company aims to capitalize on significant opportunities to drive long-term shareholder value following its Nasdaq uplisting and rebranding efforts [2]